GGrantIndex
Sort

141,003 grants matching cytokine

Hepatitis C Pathogenesis & The Human Genome

$643,505
David L Thomas · Johns Hopkins University · R01 · FY2008 · DA

Immune reconstitution following autologous and allogeneic stem cell transplant

$643,479
Frances Hakim · Division Of Basic Sciences - Nci · ZIC · FY2016 · CA

Mechanisms of Sensitization in High Risk Corneal Grafts

$643,475
Reza Dana · Schepens Eye Research Institute · R01 · FY2011 · EY

Mechanisms of Sensitization in High Risk Corneal Grafts

$643,475
Reza Dana · Schepens Eye Research Institute · R01 · FY2012 · EY

Homeostasis and function of regulatory T cells in aging

$643,473
Claire A Chougnet · Cincinnati Childrens Hosp Med Ctr · R56 · FY2019 · AG

TrialNet: University of Florida Clinical Center and Network

$643,470
Desmond Arthur Schatz · University Of Florida · U01 · FY2010 · DK

Validation of Immunometabolic NLRX1 Therapeutics for IBD

$643,417
Andrew Leber · Biotherapeutics, Inc. · R44 · FY2021 · DK

Adipose MTP and FIT2 in the regulation of plasma lipids, obesity and atherosclerosis

$643,387
M Mahmood Hussain · Nyu Long Island School Of Medicine · P01 · FY2023 · HL

Neurosarcoidosis: Clinical Phenotype, Biomarkers and Immunopathogensis

$643,385
Carlos A Pardo-Villamizar · Johns Hopkins University · R01 · FY2024 · NS

Pathogenic Heterogeneity in Mucosal Stem Cells in Pediatric Crohn's Disease

$643,378
Wa Xian · University Of Houston · R01 · FY2020 · DK

Engineering Skeletal Muscle WIth Biodegradable Hydrogels

$643,356
David J Mooney · Harvard University · R01 · FY2018 · DE

Neural Plasticity and Inflammatory Pain

$643,320
Clifford J Woolf · Boston Children'S Hospital · R37 · FY2012 · NS

Targeting the GDF15-GFRAL system to treat nausea and emesis

$643,266
Bart C De Jonghe · University Of Pennsylvania · R01 · FY2024 · DK

Initiators, biomarkers and mechanisms of epithelial dysfunction and immune pathogenesis in chronic rhinosinusitis and aspirin exacerbated respiratory disease (AERD)

$643,237
Robert P Schleimer · Northwestern University At Chicago · R01 · FY2018 · AI

Evaluating the Impact of Metabolic Dysfunction on Asthma Pathology and Physiology

$643,174
John V Fahy · University Of California, San Francisco · R01 · FY2025 · HL

Examining the Effects of Immulina to Increase Immune Resilience against Influenza Virus Infections

$643,143
Gailen D. Marshall · University Of Mississippi · U19 · FY2024 · AT

Molecular Basis of Pathogenicity of IgA1-containing Immune Complexes

$643,133
Jan Novak · University Of Alabama At Birmingham · R01 · FY2024 · DK

Eosinophilic Esophagitis and Food Allergy

$643,086
Marc E. Rothenberg · Icahn School Of Medicine At Mount Sinai · U19 · FY2014 · AI

IL-33 Blockade as a Novel Therapeutic for T-cell Mediated Hypercytokinemia Syndromes

$643,084
Edward M Behrens · Children'S Hosp Of Philadelphia · R01 · FY2016 · AI

Randomized Trial of Rosiglitazone for Ulcerative Colitis

$643,083
University Of Pennsylvania · R01 · FY2002 · DK

Novel Mechanisms of Pulmonary Fibrosis

$643,080
Francis X McCormack · University Of Cincinnati · R01 · FY2023 · HL

Small-molecule STAT3 degraders

$643,055
Shaomeng Wang · University Of Michigan At Ann Arbor · R01 · FY2020 · CA

Physiomimetic Models of Endometrioma Initiation

$643,049
Brendan A. Harley · University Of Illinois At Urbana-Champaign · R01 · FY2025 · HD

Genome-wide fine-mapping of H. pylori-stimulated human T cell responses

$643,016
Steven F Moss · University Of Rhode Island · U19 · FY2012 · AI

Identification of REV-ERB inverse agonists for cancer immunotherapy

$643,014
Laura A Solt · Scripps Florida · R01 · FY2020 · CA